| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 42.92M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MESO returned +7.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -5.8% |
| 1 year | +7.5% |
| 5 years | +30.2% |
| 10 years | +69.7% |
| All-time high | $99.00 (Jul 2011) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MESO would be worth today ›No. Mesoblast Limited has not paid a dividend in the past 12 months.
Mesoblast Limited stock trades on NASDAQ under the ticker symbol MESO.
Mesoblast Limited is part of the Healthcare sector.
Mesoblast Limited has a market cap of 2.20B USD, based on the latest quote.
Mesoblast Limited is expected to report earnings around Aug 27, 2026. That date is an estimate and has not been confirmed by the company.
